COR - Cencora - Stock Price & Dividends

Exchange: USA Stocks • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03073E1055

Pharmaceuticals, Healthcare Products, Medical Supplies, Vaccines, Diagnostics

Cencora Inc. is a leading pharmaceutical sourcing and distribution company that operates through two main segments: U.S. Healthcare Solutions and International Healthcare Solutions.

The U.S. Healthcare Solutions segment is a comprehensive healthcare partner, providing a wide range of products and services to various healthcare providers, including acute care hospitals, health systems, retail pharmacies, mail order pharmacies, medical clinics, and long-term care facilities. The company distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies, and equipment, as well as offers pharmacy management, staffing, and consulting services. Additionally, it provides supply management software, packaging solutions, clinical trial support, product post-approval, and commercialization support services to its customers.

Furthermore, this segment offers data analytics, outcomes research, and additional services to biotechnology and pharmaceutical manufacturers. It also distributes products to the companion animal and production animal markets, including pharmaceuticals, vaccines, parasiticides, diagnostics, and micro feed ingredients. Moreover, the company provides sales force services to manufacturers and distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products to healthcare providers, including physicians specializing in oncology and other disease states.

The International Healthcare Solutions segment focuses on international pharmaceutical wholesale and related services, distributing pharmaceuticals, healthcare products, and services to pharmacies, doctors, health centers, and hospitals primarily in Europe. The company also provides global commercialization services and specialty transportation and logistics services for the biopharmaceutical industry.

With a rich history dating back to 2001, Cencora Inc. was formerly known as AmerisourceBergen Corporation and changed its name to Cencora Inc. in August 2023. The company is headquartered in Conshohocken, Pennsylvania, and can be found online at https://www.cencora.com.

Drawdown (Underwater) Chart

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

Overall Trend and Yearly Seasonality

Drawdown / Underwater Chart for COR - Cencora  - Stock Price & Dividends

COR Stock Overview

Market Cap in USD 43,951m
Sector Healthcare
Industry Medical Distribution
GiC SubIndustry Health Care Distributors
TER 0.00%
IPO / Inception 1995-04-04

COR Stock Ratings

Growth 5y 92.8
Fundamental 46.0
Dividend 50.6
Rel. Performance vs Sector 0.22
Analysts 4.00/5
Fair Price Momentum 266.06 USD
Fair Price DCF 487.56 USD

COR Dividends

Dividend Yield 12m 0.86%
Yield on Cost 5y 2.54%
Dividends CAGR 5y 4.20%
Payout Consistency 99.6%

COR Growth Ratios

Growth 12m 26.43%
Growth Correlation 12m 55.2%
Growth Correlation 3m -51%
CAGR 5y 24.08%
CAGR/Mean DD 5y 4.76
Sharpe Ratio 12m 1.26
Alpha vs SP500 12m 0.96
Beta vs SP500 5y weekly 0.58
ValueRay RSI 75.03
Volatility GJR Garch 1y 21.78%
Price / SMA 50 1.81%
Price / SMA 200 2.6%
Current Volume 847.8k
Average Volume 20d 1534.1k

External Links for COR Stock

News
Wall Street JournalBenzingaYahoo Finance
Tweets
XStocktwits
Fund Manager Positions
DataromaStockcircle
What is the price of COR stocks?
As of October 22, 2024, the stock is trading at USD 236.54 with a total of 847,779 shares traded.
Over the past week, the price has changed by +5.22%, over one month by +3.70%, over three months by +5.49% and over the past year by +26.30%.
What are the forecast for COR stock price target?
According to ValueRays Forecast Model, COR Cencora will be worth about 290.2 in October 2025. The stock is currently trading at 236.54. This means that the stock has a potential upside of +22.68%.
Issuer Forecast Upside
Wallstreet Target Price 261.1 10.4
Analysts Target Price 209.7 -11.4
ValueRay Target Price 290.2 22.7